The Drug Benefit List is a listing of the drugs provided as a benefit by the Non-Insured Health Benefits (NIHB) Program. The listed drugs are those primarily used in a home or ambulatory setting.
The purpose of the Drug Benefit List is to:
Benefit Updates to the Drug Benefit List are generally issued on a quarterly basis.
A prescription from a licensed practitioner is required for any listed drug to be processed as a benefit. Practitioners are those people authorized to prescribe drugs within the scope of practice in their province or territory.
The information contained in this electronic version of the Non-Insured Health Benefits Drug Benefit List requires knowledgeable interpretation and is intended primarily for professional health care practitioners, pharmacies, hospitals and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.
The Drug Benefit List is also published in print format once a year in April. To receive a print copy, providers must obtain a fax request form from one of the Non-Insured Health Benefits Toll-Free Inquiry Centres.
The quarterly update is a cumulative listing of any changes to the NIHB Drug Benefit List since last published, including additions and deletions of items, replacement of Drug Identification Numbers (DINs), limited use benefits, drugs with a status change, drugs with name changes, drugs removed from the Canadian market and drugs discontinued by the manufacturer.
The updates are also reflected in the most recent electronic version of the Non-Insured Health Benefits Drug Benefit List.
For access to complete listing of published DBL updates, as well as a variety of related documents, visit the Non-Insured Health Benefits Reports and Publications section.